This federal contract award, valued at $3,063.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of REVATIO 20 MG TABLET 90S, a medication used for the treatment of pulmonary arterial hypertension. The contract has an ultimate completion date of December 17, 2024 and is a Firm Fixed Price contract. This award is not associated with a set-aside program and is an open competition contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/17/25, 9:56 AM